KC
GCVRZ

Knuff & Co’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Knuff & Co’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,000
Closed -$7K – 137
2019
Q1 		$7K Buy
+15,000
New +$7K 0.01% 126

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Knuff & Co's GCVRZ Position: Q2 2019 in Review

Knuff & Co sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2019, closing a stake of 15,000 shares — an estimated $7K sold.

Knuff & Co first reported a position in GCVRZ in Q1 2019 and held it in 1 quarter. The position peaked at $7K in Q1 2019. 104 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2019.

  • Knuff & Co reported no remaining Sanofi Contingent Value Rights position as of Q2 2019 after selling out during the quarter.
  • Knuff & Co sold 15,000 Sanofi Contingent Value Rights shares in Q2 2019, an estimated $7K.
  • Knuff & Co first reported a position in Sanofi Contingent Value Rights in Q1 2019 and held it in 1 quarter.
  • Knuff & Co's Sanofi Contingent Value Rights position peaked at $7K in Q1 2019.
  • 104 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2019.

Based on Knuff & Co's 13F filing for Q2 2019, filed 8 Aug 2019.